RMAX · Re/Max Holdings, Inc.

Current Thesis

RMAX is a merger-arb instrument, not a tradable narrative. On 2026-04-27 The Real Brokerage (REAX) agreed to acquire it in an ~$880M enterprise-value deal that the headline framed at $13.80/share. That number is a relic of REAX's $2.68 close on 2026-04-24; the consideration is almost entirely stock 5.152 REAX shares per RMAX share, with a hard cash pool of only $60–80M total. With REAX at $1.68 (2026-06-07), the stock leg is worth ~$8.66, and the blended value (a thin slice of cash-electing holders prorated at $13.80) sits in the low-$9s. RMAX trades ~$9.05 effectively at parity to what the deal is actually worth today. The M&A gap already played out (spike toward $13 on announcement, then a bleed back to $9 as REAX faded ~37%). What remains is a leveraged REAX proxy with completion risk attached and no spread worth underwriting. For a momentum book this is a pass.

Bull Case

• Signed, board-approved deal, not a rumor (2026-04-27): ~$880M EV at a stated ~7x 2025 EBITDA, with a new holding company "Real REMAX Group," HQ Miami, Tamir Poleg as CEO. Provides a soft floor under a stock that Wolf Street pegged at −85% from peak the day of announcement.
• Embedded leveraged REAX call: each RMAX share carries 5.152 REAX shares. If REAX (analyst median PT $4.75, range $4.00–$8.00 per MarketBeat, 2026-06) has bottomed and the 180,000-agent, 120-country rollup rerates, RMAX gives ~5:1 upside to REAX on the stock portion. REAX back to the $2.68 signing level ⇒ blended ~$13 (+~40% from $9.05).
• Cash floor for a minority: the $60–80M pool cashes out ~15–25% of equity at $13.80 regardless of REAX, a thin cushion the pure-stock math understates.
• Both boards committed with real break fees (per merger agreement, 2026-04): RMAX owes $25M to walk, REAX owes $31M plus a $36M regulatory termination fee friction that discourages a casual collapse.

Bear Case

• The $13.80 is fiction at spot. REAX −37% since signing means the stock leg is ~$8.66 and falls ~5.15:1 with REAX because cash is capped. The trade is REAX exposure at a slim discount, dressed as a takeout.
• Risk/reward is inverted for a fresh long: a few percent to blended value vs ~35–40% downside if the deal breaks (RMAX reverts toward pre-deal ~$6 / 52-week low $5.46). The spread is thin precisely because the consideration is already mark-to-market REAX.
• Long, condition-heavy path to close (per 6-K/DEFA14A, 2026-04/06): requires both shareholder votes, HSR expiry, Form S-4 effectiveness, British Columbia court orders, and a 10-for-1 Real share consolidation. REAX holders must approve a heavily dilutive issuance with their own stock down ~37% deal-fatigue risk rises as the acquirer slides. Close only guided to H2 2026.
• No organic story underneath: two impaired brokerage equities merging into a frozen-transaction housing market. RMAX standalone Class A market cap is ~$190M (2026-06-07).

Setup & Price Structure

• Price ~$9.05 (2026-06-07); opened $8.87. 52-week range $5.46–$11.62 mid-range, pinned to deal math rather than trend.
• The chart is a dead event stock: pre-deal ~$6 → spike toward $13 on 2026-04-27 → bled to ~$9 as REAX faded to $1.68.
• Daily prints track REAX, not RMAX order flow; RSI and moving-average signals carry no information on a pinned arb name.
• Anchor levels: blended deal value low-$9s (moves with REAX); break-downside ~$6 toward the $5.46 floor; cash-cap ceiling $13.80 only reachable if REAX re-rates to ~$2.68.

Catalyst Calendar (next 30 days)

• ~late June 2026 (est.) Form S-4 / proxy statement effectiveness; management flagged roadshow/communication activity in early June 2026 (425 filings, CEO site visit).
• HSR waiting period clock running; expiry date undisclosed, plausibly within the window.
• Special shareholder meetings (Real + RE/MAX votes) not yet dated; expected to follow S-4 effectiveness, likely beyond 30 days.
• REAX Q2 print ~early Aug 2026 (outside window) relevant because RMAX is a REAX proxy; weak REAX results drag blended value 1:1.
• Deal close guided H2 2026. No hard, dated binary inside 30 days.

What Would Change Our Mind

• A near-dated close with a firm meeting date and the spread widening materially (REAX stable, RMAX gapping below blended value) would turn this into a real arb with quantifiable return-to-close worth a probe sized to break risk, not momentum.
• REAX itself basing and re-rating (reclaiming ~$2.20–$2.68 on improving agent-count/revenue trend) would lift blended consideration and make RMAX a leveraged way to express that but the cleaner expression would be REAX directly.
• Absent either, there is no momentum leg here; the name stays a watch-only special situation.

Correlation Notes

• RMAX is, by construction, a leveraged REAX proxy ~0.85 effective beta to REAX, with the stock leg (5.152x) driving ~75–80% of consideration and the capped cash pool damping the rest.
• Secondary read-through to the residential brokerage/transaction-volume complex (COMP, EXPG, ANYW, HOUS) and mortgage-rate sensitivity, but those are noise relative to the REAX peg.
• Theme-discovery tags pulled toward cyclicals/defensive (oil-crash-rate-relief, consumer-defensive) are misclassifications the only live driver is the merger and REAX's share price.